|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/23/22 Commonwealth Income & Growth Fd V 10-Q 6/30/22 46:1.7M Blueprint/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 373K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
11: R1 Cover HTML 64K
12: R2 Condensed Balance Sheets HTML 85K
13: R3 Condensed Balance Sheets (Parenthetical) HTML 20K
14: R4 Condensed Statements of Operations (Unaudited) HTML 72K
15: R5 Condensed Statement of Partners' Equity HTML 43K
(Unaudited)
16: R6 Condensed Statements of Cash Flow (Unaudited) HTML 30K
17: R7 Business HTML 22K
18: R8 Summary of Significant Accounting Policies HTML 28K
19: R9 Information Technology, Medical Technology, HTML 26K
Telecommunications Technology, Inventory
Management and Other Business-Essential Capital
Equipment ("Equipment")
20: R10 Related Party Transactions HTML 33K
21: R11 Notes Payable HTML 29K
22: R12 Supplemental Cash Flow Information HTML 20K
23: R13 Commitments and Contingencies HTML 27K
24: R14 Summary of Significant Accounting Policies HTML 33K
(Policies)
25: R15 Summary of Significant Accounting Policies HTML 19K
(Tables)
26: R16 Information Technology, Medical Technology, HTML 21K
Telecommunications Technology, Inventory
Management and Other Business-Essential Capital
Equipment ("Equipment") (Tables)
27: R17 Related Party Transactions (Tables) HTML 31K
28: R18 Notes Payable (Tables) HTML 26K
29: R19 Supplemental Cash Flow Information (Tables) HTML 19K
30: R20 Business (Details Narrative) HTML 19K
31: R21 Summary of Significant Accounting Policies HTML 20K
(Details)
32: R22 Summary of Significant Accounting Policies HTML 18K
(Details Narrative)
33: R23 Information Technology Medical Technology HTML 27K
Telecommunications Technology Inventory Management
Equipment and other BusinessEssential Capital
Equipment (Equipment) (Details)
34: R24 Information Technology Medical Technology HTML 24K
Telecommunications Technology Inventory Management
Equipment and other BusinessEssential Capital
Equipment (Equipment) (Details Narrative)
35: R25 Related Party Transactions (Details) HTML 21K
36: R26 Related Party Transactions (Details Narrative) HTML 26K
37: R27 Notes Payable (Details) HTML 22K
38: R28 Notes Payable (Details 1) HTML 26K
39: R29 Notes Payable (Details Narrative) HTML 16K
40: R30 Supplemental Cash Flow Information (Details) HTML 17K
41: R31 Commitments and Contingencies (Details Narrative) HTML 37K
44: XML IDEA XML File -- Filing Summary XML 77K
42: XML XBRL Instance -- cigf5_10q_htm XML 291K
43: EXCEL IDEA Workbook of Financial Reports XLSX 60K
8: EX-101.CAL XBRL Calculations -- cigf5-20220630_cal XML 76K
10: EX-101.DEF XBRL Definitions -- cigf5-20220630_def XML 94K
7: EX-101.LAB XBRL Labels -- cigf5-20220630_lab XML 323K
9: EX-101.PRE XBRL Presentations -- cigf5-20220630_pre XML 241K
6: EX-101.SCH XBRL Schema -- cigf5-20220630 XSD 84K
45: JSON XBRL Instance as JSON Data -- MetaLinks 151± 204K
46: ZIP XBRL Zipped Folder -- 0001654954-22-011685-xbrl Zip 93K
EXHIBIT 31.2
31.2 RULE 15d-14(a) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Kimberly A. Springsteen-Abbott, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Commonwealth Income & Growth Fund V (the Registrant); |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have: |
|
|
|
|
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| (b) | Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| (c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| (d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
|
|
|
|
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
|
|
|
|
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
| |
|
| |
| Principal Financial Officer |
|
|
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/23/22 | |||
| 8/22/22 | ||||
| For Period end: | 6/30/22 | NT 10-Q | ||
| List all Filings | ||||